Researchers prepared recombinant SRS67 and SRS20A proteins and generated corresponding polyclonal antibodies to investigate the two poorly characterized proteins. Immunofluorescence analysis detected punctate signals surrounding the parasite membrane for both proteins, supporting their localization at the parasite surface and their involvement in surface-associated biological processes. In vitro phenotypic assays then showed that the prepared antibodies significantly inhibited T. gondii invasion of host cells and its proliferation inside those cells.

The study assessed antibody effects and protein immunization in two mouse infection models. In the acute RH infection model, immunization with SRS67, SRS20A or both proteins together increased mouse survival by approximately 60%. Combined immunization also delayed mortality by one to two days. In the chronic PRU infection model, antibody intervention reduced brain cyst burden by more than 85% and markedly attenuated meningeal thickening and neuronal necrosis. These results describe experimental outcomes in mice; the supplied findings do not establish effectiveness in people, the durability of protection or how broadly the results extend beyond these models.

The reported mechanisms involved both parasite-associated effects and changes in host responses. During acute infection, SRS67 upregulated the expression of the cytokines TNF-α and IL-18, while both SRS67 and SRS20A downregulated IFN-γ. The investigators associated this pattern with limiting excessive immune-mediated tissue damage. An elevated glutathione level suggested participation of the proteins in antioxidant regulation. During chronic infection, combined immunization synergistically increased superoxide dismutase activity, which the study linked with resistance to oxidative stress, while decreased IFN-γ expression was associated with maintenance of immune homeostasis. Together, the observations identify SRS67 and SRS20A as potential antibody targets for anti-Toxoplasma strategies, while the study’s preliminary scope limits the conclusions to the reported cell assays and mouse models.

Subject of Research: Experimental assessment of SRS67 and SRS20A as antibody targets against Toxoplasma gondii infection in cells and mice.

Article Title: Preliminary study on expression and functions of Toxoplasma gondii SRS67 and SRS20A proteins

Article References: Chen, X., Yi, T., Ma, W., Liang, X., Niu, S., Du, M., Zhou, S., Li, Q., & Yin, D. (2026). Preliminary study on expression and functions of Toxoplasma gondii SRS67 and SRS20A proteins. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07629-1

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07629-1

Keywords: Toxoplasma gondii, SRS67, SRS20A, surface proteins, polyclonal antibodies, host cell invasion, mouse infection models, brain cyst burden, immune regulation, oxidative stress, Preliminary, expression

The AMA1 family of proteins has long fascinated parasitologists. These molecules sit at the apical tip of apicomplexan parasites, the group that includes the agents of malaria, cryptosporidiosis and toxoplasmosis, and they contribute to the invasion machinery that lets these organisms push their way into host cells. In Plasmodium, the malaria parasite, AMA1 has been extensively studied as a vaccine candidate because antibodies against it can block red blood cell invasion. Toxoplasma gondii carries several AMA1-like proteins, and previous work has shown that some of them are used at specific stages of the parasite’s life cycle. What has remained murky is the role of the sporozoite-specific member, sporoAMA1, which is predicted to be expressed when the parasite exists as a sporozoite inside the oocyst, the environmentally resistant stage shed in the feces of cats, the parasite’s definitive host.

To interrogate this protein, the team took a genetic approach, generating parasite lines in which the sporoAMA1 gene could be tagged and manipulated in its endogenous context. An early surprise came from the microscopy: when the researchers attempted to detect fluorescently tagged versions of the protein, the signal proved elusive, and endogenous tagging failed to yield detectable fluorescence. This kind of negative result is familiar to anyone working with low-abundance proteins in difficult-to-study life stages, and it underscores how technically demanding it is to study the sexual and environmental stages of T. gondii, which cannot be grown in standard cell culture the way the fast-replicating tachyzoite stage can.

However, the absence of a fluorescent signal did not mean the gene was silent. Using reverse transcription polymerase chain reaction, or RT-PCR, the researchers readily detected sporoAMA1 transcripts in bradyzoites, the slowly dividing stage that dwells inside tissue cysts during chronic infection; in the sexual stages that develop in the cat intestine; and in oocysts. The presence of messenger RNA across these stages suggested that the protein is genuinely expressed during the parts of the life cycle devoted to persistence and transmission, even if the protein itself is present at levels too low or in conformations too difficult to visualize with standard tagging strategies. The study also identified distinct forms of the sporoAMA1 protein across bradyzoites, sexual stages and oocysts, hinting at stage-specific processing or isoform usage that may fine-tune the protein’s function as the parasite transitions between environments as different as a host cell vacuole and the outside world.

The decisive experiments came from deleting or disrupting the gene and asking what happens to the parasite at each stage of its life cycle. In the tachyzoite stage, the rapidly dividing form responsible for acute disease, the answer was: essentially nothing. Parasites lacking functional sporoAMA1 grew normally in vitro, demonstrating that the protein is dispensable for the standard laboratory measures of tachyzoite fitness. This result is significant in itself, because it rules out a broad, housekeeping role in host-cell invasion during the acute phase and sharpens the question of why the parasite maintains this gene at all.

The answer emerged when the researchers turned to the chronic phase of infection. When mice were infected with parasites lacking sporoAMA1, the formation of tissue cysts was markedly impaired. Cyst formation is the process by which tachyzoites convert into bradyzoites and assemble the walled structures that can persist in brain and muscle tissue for the lifetime of the host. A reduced cyst formation rate means fewer persistent reservoirs of infection, and indeed the mutant parasites showed defects in establishing chronic infection. In practical terms, a parasite unable to express sporoAMA1 is a parasite that struggles to settle in for the long haul, which is precisely the strategy that makes T. gondii so successful in nature.

The defects did not stop at chronicity. The team also examined the parasite’s sexual cycle, which occurs exclusively in cats and culminates in the shedding of oocysts into the environment. Here again, loss of sporoAMA1 took a measurable toll: oocyst production was reduced, and the sporulation process, by which oocysts mature in the soil and become infectious to new hosts, was also inefficient. Oocyst yield and sporulation are the bottleneck steps of transmission for the foodborne and waterborne routes of toxoplasmosis, so a protein that influences both stages sits at a critical junction in the parasite’s epidemiology. Taken together, the phenotype of the sporoAMA1-deficient parasites traces a coherent arc: normal acute growth, defective chronic persistence, impaired sexual development, and compromised environmental transmission.

These findings reframe sporoAMA1 as a stage-dependent factor that links chronic infection and transmission, two phases of the parasite’s life that are often studied separately. The result also fits a broader pattern emerging from apicomplexan biology: different members of the AMA1 family appear to have been specialized for different life cycle stages and different host environments, rather than acting redundantly. For T. gondii, whose life cycle shuttles between asexual replication in intermediate hosts and sexual reproduction in cats, having a dedicated AMA1 protein for the sporozoite and sexual phases makes evolutionary sense, since the mechanical and immunological challenges of invading cells in the cat intestine or surviving sporulation in soil differ substantially from those faced by a tachyzoite in mouse blood.

The work also carries practical implications. Most current research into toxoplasmosis focuses on the tachyzoite stage because it is easy to culture, yet interventions aimed at blocking transmission would need to target the sexual and oocyst stages in cats or the sporozoite as it emerges from mature oocysts. A protein that is dispensable for tachyzoite growth but required for cyst formation, oocyst production and sporulation is an attractive candidate for such transmission-blocking strategies, whether through drugs, vaccines aimed at the definitive host, or genetic approaches to controlling oocyst shedding on farms and in the environment. The study’s demonstration that sporoAMA1 transcripts can be detected across bradyzoites, sexual stages and oocysts also provides researchers with a molecular handle for future work on stages that remain among the least accessible in the entire parasite.

As with any brief report, questions remain. The failure of endogenous tagging to produce detectable fluorescence leaves the precise subcellular localization of sporoAMA1 unresolved, and the distinct protein forms observed across stages invite deeper biochemical characterization. Whether the protein acts directly in invasion, in cyst wall biology, in oocyst wall assembly, or in some combination of these processes will require further study. Nevertheless, the core conclusion stands on solid genetic ground: removing sporoAMA1 leaves acute infection largely intact while undermining nearly every step that matters for persistence and spread. For a parasite whose global success rests on its ability to hide in tissue cysts and to seed the environment with hardy oocysts, that combination of vulnerabilities identifies sporoAMA1 as one of the more intriguing molecular targets to have emerged in toxoplasmosis research in recent years, and it offers a reminder that the most consequential stages of a parasite’s life are often the hardest ones to see in the laboratory.

Subject of Research: Stage-dependent function of the sporoAMA1 protein in chronic infection and transmission stages of Toxoplasma gondii

Article Title: Stage-dependent expression of sporoAMA1 links chronic infection and transmission in Toxoplasma gondii

Article References: Zhang, Z., Lin, Y., Xie, F., Xie, Y., Song, X., Liu, X., Suo, X., Tang, X., & Hu, D. (2026). Stage-dependent expression of sporoAMA1 links chronic infection and transmission in Toxoplasma gondii. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07650-4

Image Credits: AI Generated

DOI: 10.1186/s13071-026-07650-4

Keywords: Toxoplasma gondii, sporoAMA1, AMA1 protein family, bradyzoites, tissue cysts, oocysts, sporulation, chronic infection, apicomplexan parasites, parasite transmission, host-cell invasion, Parasites & Vectors